Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, industry trends, and guideline public company metrics.
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, industry trends, and guideline public company metrics.
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...Mercer Capital
This document provides an overview and market analysis of the medical device industry. It discusses key trends influencing demand, including an aging global population driving higher healthcare spending. Regulatory and reimbursement landscapes play a large role in device adoption and pricing. The transition to value-based care may lead to lower procedure volumes and reimbursement rates. Medical device companies face competitive pressures to continuously innovate and obtain necessary regulatory clearances for new products.
Mercer Capital's Value Focus: Healthcare Facilities | Year-End 2015 | Sub-Sec...Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes a macroeconomic trends, industry trends, and guideline public company metrics.
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes a macroeconomic trends, industry trends, and guideline public company metrics.
Mercer Capital's Value Focus: Healthcare Facilities | Year-End 2014Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes a macroeconomic trends, industry trends, and guideline public company metrics.
Consumer-Centric Healthcare: 2015--The Tipping Point Has Arrived (Report by William Blair)
Consumers—in tandem with disruptive healthcare technology and healthcare services providers—are the key to solving many of US healthcare's woes, particularly the unsustainably high cost of care.
Public exchanges, private exchanges, and high-deductible health plans are growing quickly. Disruptive forces of competition will create a lower-cost system that promotes the growth of highly efficient, low-cost, and high-quality providers and technologies.
The continued movement of financial and quality risk back to providers (and increasingly to consumers themselves) is encouraging providers and consumers to seek preventive medicine, cost efficiency, clinical efficacy, and overall value in healthcare. In turn, this could drive significant change regarding the primary point of care delivery (rapidly moving outside the hospital), the overall cost of healthcare and investment decisions made by healthcare providers.
Consumer-centric healthcare providers will experience strong top- and bottom-line growth over the coming years. Investors in both the public and private-equity markets will achieve superior long-term returns by identifying and investing in these companies.
The document discusses the impact of COVID-19 on the life science and healthcare industry in the US. It notes that the pandemic has significantly strained healthcare capacity and caused spending on the sector to increase. The pharmaceutical and medical equipment segments have seen high demand for COVID-19 tests, supplies, and research into vaccines and treatments. Government relief packages have allocated billions towards healthcare services, facilities, and supporting the development of response efforts. Overall, the pandemic is driving major changes across the industry and highlighting vulnerabilities in the US healthcare system.
2021 Healthcare Trends: Embracing an Unpredictable FutureHealth Catalyst
We’re putting 2020 in the rearview mirror and gazing into the crystal ball to see what 2021 holds. Stephen Grossbart, PhD, and Dan Orenstein, JD, tackle the challenge of predicting what’s next for healthcare in 2021. Stephen and Dan discuss the trends and policies most impactful to the industry and attempt to answer the following questions on everyone’s mind.
- Healthcare technology—Where is it headed? What’s the next big thing?
- Care delivery—How will COVID-19 continue to impact healthcare systems, physicians, and patients? What changes will the industry make to prepare for future pandemics? What will happen with value-based care?
- The new Biden administration—What changes will it make that will impact healthcare? What will the Supreme Court/Congress do about the ACA?
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, industry trends, and guideline public company metrics.
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...Mercer Capital
This document provides an overview and market analysis of the medical device industry. It discusses key trends influencing demand, including an aging global population driving higher healthcare spending. Regulatory and reimbursement landscapes play a large role in device adoption and pricing. The transition to value-based care may lead to lower procedure volumes and reimbursement rates. Medical device companies face competitive pressures to continuously innovate and obtain necessary regulatory clearances for new products.
Mercer Capital's Value Focus: Healthcare Facilities | Year-End 2015 | Sub-Sec...Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes a macroeconomic trends, industry trends, and guideline public company metrics.
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes a macroeconomic trends, industry trends, and guideline public company metrics.
Mercer Capital's Value Focus: Healthcare Facilities | Year-End 2014Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes a macroeconomic trends, industry trends, and guideline public company metrics.
Consumer-Centric Healthcare: 2015--The Tipping Point Has Arrived (Report by William Blair)
Consumers—in tandem with disruptive healthcare technology and healthcare services providers—are the key to solving many of US healthcare's woes, particularly the unsustainably high cost of care.
Public exchanges, private exchanges, and high-deductible health plans are growing quickly. Disruptive forces of competition will create a lower-cost system that promotes the growth of highly efficient, low-cost, and high-quality providers and technologies.
The continued movement of financial and quality risk back to providers (and increasingly to consumers themselves) is encouraging providers and consumers to seek preventive medicine, cost efficiency, clinical efficacy, and overall value in healthcare. In turn, this could drive significant change regarding the primary point of care delivery (rapidly moving outside the hospital), the overall cost of healthcare and investment decisions made by healthcare providers.
Consumer-centric healthcare providers will experience strong top- and bottom-line growth over the coming years. Investors in both the public and private-equity markets will achieve superior long-term returns by identifying and investing in these companies.
The document discusses the impact of COVID-19 on the life science and healthcare industry in the US. It notes that the pandemic has significantly strained healthcare capacity and caused spending on the sector to increase. The pharmaceutical and medical equipment segments have seen high demand for COVID-19 tests, supplies, and research into vaccines and treatments. Government relief packages have allocated billions towards healthcare services, facilities, and supporting the development of response efforts. Overall, the pandemic is driving major changes across the industry and highlighting vulnerabilities in the US healthcare system.
2021 Healthcare Trends: Embracing an Unpredictable FutureHealth Catalyst
We’re putting 2020 in the rearview mirror and gazing into the crystal ball to see what 2021 holds. Stephen Grossbart, PhD, and Dan Orenstein, JD, tackle the challenge of predicting what’s next for healthcare in 2021. Stephen and Dan discuss the trends and policies most impactful to the industry and attempt to answer the following questions on everyone’s mind.
- Healthcare technology—Where is it headed? What’s the next big thing?
- Care delivery—How will COVID-19 continue to impact healthcare systems, physicians, and patients? What changes will the industry make to prepare for future pandemics? What will happen with value-based care?
- The new Biden administration—What changes will it make that will impact healthcare? What will the Supreme Court/Congress do about the ACA?
Good Foundations: Building Healthcare M&A and Real EstateDuff & Phelps
Several fundamental shifts have changed the face of healthcare in North America. A new report, “Good Foundations: Building Healthcare M&A and Real Estate,” published in association with Mergermarket, explores the way healthcare companies are increasingly embracing innovative ways to raise capital and fund future projects, including selling real estate assets to third-party capital providers.
As per Centers for Medicare & Medicaid Services predicted that Healthcare expenditures reach beyond $5.7 trillion in the US include payments for all healthcare costs, including pharmaceuticals, equipment, and technology from 2010 to 2026.
The worldwide health industry was valued at $8.45 trillion out of 2018.
Worldwide healthcare spending could reach more than $10 trillion by 2022.
The US has the best healthcare spending, sitting at $10,224 per capita.
The US spends twice what different nations do on healthcare.
There are 784,626 organizations in the US healthcare area.
McKesson is the greatest US healthcare organization with a yearly income of $208.3 billion.
The web of things (IoT) can bring down the expenses of functional and clinical failures by $100 billion every year.
64% of doctors accept the IoT can assist with lessening the weight on medical caretakers and specialists.
28% of China's populace utilizes associated health gadgets, the most noteworthy on the planet.
Succeeding in Population Health Management: Why the Right Tools MatterHealth Catalyst
The document discusses trends in population health management and value-based care models. It notes that the number of accountable care organizations (ACOs) and lives covered by ACOs is growing significantly. However, some ACOs are also exiting programs due to challenges in improving performance while lowering costs. Success requires comprehensive data, powerful analytics platforms, and expertise to navigate changes. The transition to value-based models presents opportunities but also challenges for healthcare organizations.
A new report from PwC’s Health Research Institute predicts that insurance companies will be spending more to pay for prescription drugs starting next year, from around 3% to almost 6% by 2027. Here’s more forecasts on medical spending from the report:
•Generics: Almost half of the estimated sales from the top 100 brand-name drugs won’t be affected by generic competition for another three years.
•Specialty drugs: Spending on specialty drugs — such as biologics or rare disease treatments — has already been growing over the past five years, but by 2020 these drugs may make up more than half of all U.S. drug spending.
•Chronic disease: 85% of all employer-provided insurance spending is on chronic conditions, and obesity and diabetes will be the two top conditions that will account for spending in 2020.
The document discusses trends in healthcare following the 2012 US presidential election. It predicts that healthcare spending will need to become more sustainable, regulations will continue increasing, and payment models will shift more towards value-based systems. It also notes pressures on hospital and physician margins, and trends towards shared risk arrangements between payers and providers. The "new normal" of healthcare is said to involve greater efficiency, effectiveness, transparency, interconnectivity, and convenience for patients.
Reasons Why You Need An Experienced Account Managergingin4
The document discusses several key driving forces that will shape the future of the pharmaceutical and biotech industries, including models of change in healthcare, the quest for value over cost and quality, and various political scenarios and their implications. It analyzes trends in healthcare spending, quality, and reform proposals. The main points are that a physician-centric view is no longer sufficient; affordability and third party perspectives must be considered; assumptions about specialty drug models may be overly optimistic; and partnerships with payers are necessary to develop strategically sound plans for new markets and customers.
The document discusses Kindred Healthcare's strategy to develop partnerships between acute care hospitals and post-acute care providers. It notes the increasing demand for post-acute services, changing payment models, and opportunities to better coordinate care across settings. Kindred aims to partner with hospitals to improve outcomes, reduce readmissions, and support new payment models through its diverse post-acute services and experience managing post-acute episodes of care. Examples of Kindred's partnerships with specific hospitals are also mentioned.
This document is a research paper analyzing employment and labor trends affecting Hospital Corporation of America (HCA) and the healthcare industry. It provides an overview of the healthcare industry and compares its growth to other industries. It also describes HCA, the largest for-profit healthcare company, and analyzes its employment data. The paper examines recent employment and unemployment trends in healthcare and how government regulations like the Affordable Care Act have impacted demand for healthcare workers.
Prescription Medicines: International Costs in ContextPhRMA
Our new Prescription Medicines: International Costs in Context explains how medicines benefit patients, health care systems, and the global economy. Advances in treatment are tacking some of the world’s greatest public health challenges. These treatments provide critical savings for health care systems by reducing the need for more costly services. What’s more is the profound impact that biopharmaceutical companies have on the global economy, including the creation of high-skill jobs, R&D investment, and medicines that improve worker productivity.
Intensive Care for Medicaid McQ Quarterly 2005Craig Tanio
This document summarizes a McKinsey report analyzing the unsustainable growth of Medicaid costs in the United States. It finds that by 2009, Medicaid will consume more than 75% of new state revenue in some states and 25-50% in many others. While opportunities exist to capture savings, actually doing so will require difficult decisions and creative leadership given political and structural challenges. Reform is needed to put Medicaid on a more stable long-term footing while still serving those in need.
Using Data to Ensure a Safe Return to School During COVID-19Health Catalyst
With limited information about the novel coronavirus, industries are scrambling to create an effective response to more quickly and safely return to life before the pandemic. Data has proven to be the best way to capture information about the developing virus. With access to the latest, comprehensive COVID-19 data, decision makers in any industry—from education to healthcare—can develop a sustainable, viable approach to pandemic-era operations.
In the education sector, leaders can use accurate, up-to-date COVID-19 data to make decisions about implementing in-person or virtual learning. When states across the country instituted virtual learning as a stopgap until it was safe to resume in-person education, the most vulnerable students experienced the greatest disadvantages. As these disparities grow with continued virtual learning, it is an imperative that leaders have access to the latest coronavirus data to rapidly return to face-to-face learning.
Palestra de Rachel David no 3º Fórum Nacional da Saúde Suplementar, realizado pela Federação Nacional de Saúde Suplementar (FenaSaúde), no Sheraton WTC São Paulo Hotel, no dia 6 de outubro de 2017.
Bloomberg Intelligence: US Healthcare Outlook 2015Bloomberg LP
Entering 2015, impacts of the Affordable Care Act will continue to shape the healthcare landscape for both patients and providers. The industry may also see new product launches from medical device companies looking to offset stagnant sales.
This document discusses trends in post-acute care and long-term care. It notes increasing demands on these industries due to an aging population and rise in chronic diseases. Payment models are shifting from volume to value-based care. The adoption of health information technology, like electronic health records, in long-term care facilities still lags behind other providers. The Affordable Care Act includes provisions that could help drive the use of health IT and information exchange across settings of care including long-term care. The future will likely see increased quality measurement, care coordination, and value-based payment models to improve long-term and post-acute care.
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...MedicineAndHealthUSA
This document provides information on reducing prescription drug costs for patients, including learning drug prices, using generic medications, slicing pills, selecting alternative medications, and assistance programs. It discusses specific cost-saving strategies like comparing prices online, using $4 generic programs, Medicare Part D, and pharmaceutical company assistance. The summary focuses on high-level strategies to help a sample patient who cannot afford his medications due to lack of prescription coverage.
This document provides an overview of quantitative techniques that can be used to analyze the local post-acute healthcare market for a given organization. It discusses calculating metrics like utilization rates, market share, market segmentation, market competitiveness/concentration, and referral source trends to understand the market dynamics. The purpose is to demonstrate possible marketing strategies based on such an analysis of the local market conditions.
The document analyzes the healthcare industry in the U.S. and how IT can help small and medium enterprises provide insurance to employees. It identifies four key factors impacting the industry: the Affordable Care Act, digital/IT infrastructure, advances in omics sciences, and the rising global middle class. Recommendations include using IT to customize insurance solutions for SMEs to help them comply with the Affordable Care Act's mandate of providing insurance to employees.
Why Data-Driven Healthcare Is the Best Defense Against COVID-19Health Catalyst
COVID-19 has given data-driven healthcare the opportunity to prove its value on the national and global stages. Health systems, researchers, and policymakers have leveraged data to drive critical decisions from short-term emergency response to long-term recovery planning.
Five areas of pandemic response and recovery stand out for their robust use of data and measurable impact on the course of the outbreak and the individuals and frontline providers at its center:
Scaling the hospital command center to pandemic proportions.
Meeting patient surge demands on hospital capacity.
Controlling disease spread.
Fueling global research.
Responding to financial strain.
The Fight Against COVID-19: A National Patient RegistryHealth Catalyst
Comprehensive COVID-19 understanding is a critical asset for adapting to pandemic needs, directing resources, developing vaccines, and planning for surges in a timely, informed manner. Because common barriers have impeded the progress of comprehensive data repositories, researchers have relied on surveillance data from population-level viral testing, which has proven insufficient. To significantly advance COVID-19 understanding, the medical community needs a digital patient registry that captures national-level data on how the virus impacts individuals differently according to comorbidities, lifestyle factors, and more. These essential insights lie in real-world evidence, which a registry can only deliver when it applies value sets to leverage clinical and claims data from health systems across the United States.
5 Trends to Watch in the Medical Device Industry in 2016Mercer Capital
Demographic shifts underlie the long-term market opportunity for medical device manufacturers. While efforts to control costs on the part of the government insurer in the U.S. may limit future pricing growth for incumbent products, a growing global market provides domestic device manufacturers with an opportunity to broaden and diversify their geographic revenue base. Developing new products and procedures is risky and usually more resource intensive compared to some other growth sectors of the economy. However, barriers to entry in the form of existing regulations provide a measure of relief from competition, especially for newly developed products.
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital
Mercer Capital's Medical Technology Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, public market trends, and comparable public company metrics.
Good Foundations: Building Healthcare M&A and Real EstateDuff & Phelps
Several fundamental shifts have changed the face of healthcare in North America. A new report, “Good Foundations: Building Healthcare M&A and Real Estate,” published in association with Mergermarket, explores the way healthcare companies are increasingly embracing innovative ways to raise capital and fund future projects, including selling real estate assets to third-party capital providers.
As per Centers for Medicare & Medicaid Services predicted that Healthcare expenditures reach beyond $5.7 trillion in the US include payments for all healthcare costs, including pharmaceuticals, equipment, and technology from 2010 to 2026.
The worldwide health industry was valued at $8.45 trillion out of 2018.
Worldwide healthcare spending could reach more than $10 trillion by 2022.
The US has the best healthcare spending, sitting at $10,224 per capita.
The US spends twice what different nations do on healthcare.
There are 784,626 organizations in the US healthcare area.
McKesson is the greatest US healthcare organization with a yearly income of $208.3 billion.
The web of things (IoT) can bring down the expenses of functional and clinical failures by $100 billion every year.
64% of doctors accept the IoT can assist with lessening the weight on medical caretakers and specialists.
28% of China's populace utilizes associated health gadgets, the most noteworthy on the planet.
Succeeding in Population Health Management: Why the Right Tools MatterHealth Catalyst
The document discusses trends in population health management and value-based care models. It notes that the number of accountable care organizations (ACOs) and lives covered by ACOs is growing significantly. However, some ACOs are also exiting programs due to challenges in improving performance while lowering costs. Success requires comprehensive data, powerful analytics platforms, and expertise to navigate changes. The transition to value-based models presents opportunities but also challenges for healthcare organizations.
A new report from PwC’s Health Research Institute predicts that insurance companies will be spending more to pay for prescription drugs starting next year, from around 3% to almost 6% by 2027. Here’s more forecasts on medical spending from the report:
•Generics: Almost half of the estimated sales from the top 100 brand-name drugs won’t be affected by generic competition for another three years.
•Specialty drugs: Spending on specialty drugs — such as biologics or rare disease treatments — has already been growing over the past five years, but by 2020 these drugs may make up more than half of all U.S. drug spending.
•Chronic disease: 85% of all employer-provided insurance spending is on chronic conditions, and obesity and diabetes will be the two top conditions that will account for spending in 2020.
The document discusses trends in healthcare following the 2012 US presidential election. It predicts that healthcare spending will need to become more sustainable, regulations will continue increasing, and payment models will shift more towards value-based systems. It also notes pressures on hospital and physician margins, and trends towards shared risk arrangements between payers and providers. The "new normal" of healthcare is said to involve greater efficiency, effectiveness, transparency, interconnectivity, and convenience for patients.
Reasons Why You Need An Experienced Account Managergingin4
The document discusses several key driving forces that will shape the future of the pharmaceutical and biotech industries, including models of change in healthcare, the quest for value over cost and quality, and various political scenarios and their implications. It analyzes trends in healthcare spending, quality, and reform proposals. The main points are that a physician-centric view is no longer sufficient; affordability and third party perspectives must be considered; assumptions about specialty drug models may be overly optimistic; and partnerships with payers are necessary to develop strategically sound plans for new markets and customers.
The document discusses Kindred Healthcare's strategy to develop partnerships between acute care hospitals and post-acute care providers. It notes the increasing demand for post-acute services, changing payment models, and opportunities to better coordinate care across settings. Kindred aims to partner with hospitals to improve outcomes, reduce readmissions, and support new payment models through its diverse post-acute services and experience managing post-acute episodes of care. Examples of Kindred's partnerships with specific hospitals are also mentioned.
This document is a research paper analyzing employment and labor trends affecting Hospital Corporation of America (HCA) and the healthcare industry. It provides an overview of the healthcare industry and compares its growth to other industries. It also describes HCA, the largest for-profit healthcare company, and analyzes its employment data. The paper examines recent employment and unemployment trends in healthcare and how government regulations like the Affordable Care Act have impacted demand for healthcare workers.
Prescription Medicines: International Costs in ContextPhRMA
Our new Prescription Medicines: International Costs in Context explains how medicines benefit patients, health care systems, and the global economy. Advances in treatment are tacking some of the world’s greatest public health challenges. These treatments provide critical savings for health care systems by reducing the need for more costly services. What’s more is the profound impact that biopharmaceutical companies have on the global economy, including the creation of high-skill jobs, R&D investment, and medicines that improve worker productivity.
Intensive Care for Medicaid McQ Quarterly 2005Craig Tanio
This document summarizes a McKinsey report analyzing the unsustainable growth of Medicaid costs in the United States. It finds that by 2009, Medicaid will consume more than 75% of new state revenue in some states and 25-50% in many others. While opportunities exist to capture savings, actually doing so will require difficult decisions and creative leadership given political and structural challenges. Reform is needed to put Medicaid on a more stable long-term footing while still serving those in need.
Using Data to Ensure a Safe Return to School During COVID-19Health Catalyst
With limited information about the novel coronavirus, industries are scrambling to create an effective response to more quickly and safely return to life before the pandemic. Data has proven to be the best way to capture information about the developing virus. With access to the latest, comprehensive COVID-19 data, decision makers in any industry—from education to healthcare—can develop a sustainable, viable approach to pandemic-era operations.
In the education sector, leaders can use accurate, up-to-date COVID-19 data to make decisions about implementing in-person or virtual learning. When states across the country instituted virtual learning as a stopgap until it was safe to resume in-person education, the most vulnerable students experienced the greatest disadvantages. As these disparities grow with continued virtual learning, it is an imperative that leaders have access to the latest coronavirus data to rapidly return to face-to-face learning.
Palestra de Rachel David no 3º Fórum Nacional da Saúde Suplementar, realizado pela Federação Nacional de Saúde Suplementar (FenaSaúde), no Sheraton WTC São Paulo Hotel, no dia 6 de outubro de 2017.
Bloomberg Intelligence: US Healthcare Outlook 2015Bloomberg LP
Entering 2015, impacts of the Affordable Care Act will continue to shape the healthcare landscape for both patients and providers. The industry may also see new product launches from medical device companies looking to offset stagnant sales.
This document discusses trends in post-acute care and long-term care. It notes increasing demands on these industries due to an aging population and rise in chronic diseases. Payment models are shifting from volume to value-based care. The adoption of health information technology, like electronic health records, in long-term care facilities still lags behind other providers. The Affordable Care Act includes provisions that could help drive the use of health IT and information exchange across settings of care including long-term care. The future will likely see increased quality measurement, care coordination, and value-based payment models to improve long-term and post-acute care.
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...MedicineAndHealthUSA
This document provides information on reducing prescription drug costs for patients, including learning drug prices, using generic medications, slicing pills, selecting alternative medications, and assistance programs. It discusses specific cost-saving strategies like comparing prices online, using $4 generic programs, Medicare Part D, and pharmaceutical company assistance. The summary focuses on high-level strategies to help a sample patient who cannot afford his medications due to lack of prescription coverage.
This document provides an overview of quantitative techniques that can be used to analyze the local post-acute healthcare market for a given organization. It discusses calculating metrics like utilization rates, market share, market segmentation, market competitiveness/concentration, and referral source trends to understand the market dynamics. The purpose is to demonstrate possible marketing strategies based on such an analysis of the local market conditions.
The document analyzes the healthcare industry in the U.S. and how IT can help small and medium enterprises provide insurance to employees. It identifies four key factors impacting the industry: the Affordable Care Act, digital/IT infrastructure, advances in omics sciences, and the rising global middle class. Recommendations include using IT to customize insurance solutions for SMEs to help them comply with the Affordable Care Act's mandate of providing insurance to employees.
Why Data-Driven Healthcare Is the Best Defense Against COVID-19Health Catalyst
COVID-19 has given data-driven healthcare the opportunity to prove its value on the national and global stages. Health systems, researchers, and policymakers have leveraged data to drive critical decisions from short-term emergency response to long-term recovery planning.
Five areas of pandemic response and recovery stand out for their robust use of data and measurable impact on the course of the outbreak and the individuals and frontline providers at its center:
Scaling the hospital command center to pandemic proportions.
Meeting patient surge demands on hospital capacity.
Controlling disease spread.
Fueling global research.
Responding to financial strain.
The Fight Against COVID-19: A National Patient RegistryHealth Catalyst
Comprehensive COVID-19 understanding is a critical asset for adapting to pandemic needs, directing resources, developing vaccines, and planning for surges in a timely, informed manner. Because common barriers have impeded the progress of comprehensive data repositories, researchers have relied on surveillance data from population-level viral testing, which has proven insufficient. To significantly advance COVID-19 understanding, the medical community needs a digital patient registry that captures national-level data on how the virus impacts individuals differently according to comorbidities, lifestyle factors, and more. These essential insights lie in real-world evidence, which a registry can only deliver when it applies value sets to leverage clinical and claims data from health systems across the United States.
5 Trends to Watch in the Medical Device Industry in 2016Mercer Capital
Demographic shifts underlie the long-term market opportunity for medical device manufacturers. While efforts to control costs on the part of the government insurer in the U.S. may limit future pricing growth for incumbent products, a growing global market provides domestic device manufacturers with an opportunity to broaden and diversify their geographic revenue base. Developing new products and procedures is risky and usually more resource intensive compared to some other growth sectors of the economy. However, barriers to entry in the form of existing regulations provide a measure of relief from competition, especially for newly developed products.
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital
Mercer Capital's Medical Technology Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, public market trends, and comparable public company metrics.
Mercer Capital's Value Focus: Medical Technology | Q2 2022Mercer Capital
The document provides a summary of a quarterly report from Mercer Capital on the medtech and device industry for Q2 2022. It includes a review of market performance, valuation multiples, operating metrics, M&A activity, and IPOs during Q1 2022. It also discusses Mercer Capital's experience providing valuation services to companies in the sector. The summary focuses on key trends in the industry including demographic shifts driving demand, healthcare spending growth in the US, the impact of third-party reimbursement, competitive factors, and regulatory environment.
A look at the trends, populations and products at play.
More questions than answers face a health industry in flux grappling with new meanings of cost, value, compliance and care delivery. Different stakeholder groups offer up different answers as they accelerate to keep pace with medical innovation. Providers, payers and businesses serving healthcare are being asked to incorporate and act on new data, integrate with new platforms and pioneer new offerings to create an increasingly accessible, connected experience. What’s driving the adaptation, and what trends are worth acting on?
It’s 2020 and healthcare is at a crossroads. Will this be the tipping point in the transformation of care or are we in for yet-another decade of radical change and resistance? Here's six key trends that I think are likely to tip the scales and shape the healthcare business model of the new era.
The document discusses opportunities in the elderly care industry. It notes that the US elderly population is growing rapidly and will increase demand for elderly care services. Major opportunities exist in developing solutions to help seniors leverage their assets for additional retirement income and providing cheaper in-home care alternatives to retirement homes. The elderly care sector is poised for consolidation as many small players currently operate with minimal market share. Overall, the aging population will drive significant industry growth and present excellent investment opportunities.
The document discusses how the Affordable Care Act aims to address problems in the US healthcare system like the large number of uninsured, rising costs, and quality and access issues. It will expand coverage to 32 million uninsured through Medicaid expansion and health insurance exchanges. Reforms to payment and delivery systems are also expected to help slow premium growth and reduce costs over time. Implementation will occur gradually through 2019, with many provisions taking effect in 2014 such as the individual mandate, Medicaid expansion, and state-based insurance exchanges.
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2015Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes a macroeconomic trends, industry trends, and guideline public company metrics.
Medicaid and Medicare at 50: Trends and ChallengesKFF
This document contains information about health insurance coverage in the United States in 2013. It shows that the largest sources of health insurance were employer-provided plans (48%), Medicaid (16%), Medicare (15%), and private plans (6%). It also notes that 13% of the population was uninsured. The document then discusses Medicaid and Medicare spending as part of the federal budget and shows these programs together account for nearly one-fourth of federal spending.
Learn about 2016 trends in government and private healthcare spending, employer costs, and the patient-as-consumer movement that's spurring new provider models.
Healthcare’s Next Revolution: Finding Success in the Medicare Shared Savings ...Health Catalyst
The document summarizes a presentation about how the shift to value-based care and revisions to the Medicare Shared Savings Program (MSSP) represent the next revolution in healthcare. It discusses how MSSP revisions will require accountable care organizations (ACOs) to take on more financial risk earlier. It argues that health systems that effectively use data to improve quality and lower costs will succeed under these changes. The document provides an overview of the MSSP and strategies that ACOs can use to succeed under the new requirements, including leveraging technology, predictive analytics, and shifting routine care management away from physicians.
The document discusses several key trends in the U.S. healthcare system: 1) Healthcare spending in the U.S. is the highest in the world at 16.4% of GDP but results in low quality of care rankings; 2) In response, the system is focusing on controlling costs and improving quality which has led to consolidation of hospitals and physician practices; 3) This has shifted medical equipment purchasing decisions from doctors to healthcare executives focused on total cost of ownership. Equipment financiers must address both clinical and financial concerns to help vendors navigate this changing landscape.
Health Information Exchange Market Size, Share | 2020-2025johnnyandrew4
The health information exchange market is projected to reach USD 2.0 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 12.2% during the forecast
The Next Revolution in Healthcare: Why the New MSSP Revisions Matter Now More...Health Catalyst
Now more than ever, we are entering a period of rapid change catalyzed by the power of data. On December 21, 2018, the Centers for Medicare and Medicaid Services (CMS) issued a final rule for the Medicare Shared Savings Program (MSSP), strengthening the financial incentives for ACOs to drive improved outcomes. The health systems that embrace data to achieve financial success will grow while the rest will struggle to compete. View this webinar for a discussion on how to prepare.
The US healthcare system didn’t develop overnight, rather, it is the culmination of a series of revolutions within wealthy parts of the world. In this webinar, we explore the high points of history that have led us to our current challenges. While care has steadily improved over time, the cost of that care has risen at a much more dramatic rate. CMS created the MSSP to help mitigate the growth of these costs while providing better care for individuals and populations. On a larger scale, the program serves to shift the healthcare industry towards fee-for-value.
Despite general frustration related to legislative involvement, history has proven that regulatory changes precede attitudinal changes and the MSSP (combined with accurate, timely data) may be just the piece of legislation to help make value-based care a reality. By viewing this webinar you will learn:
- How the US healthcare industry reached its current state.
- Why financial imperatives drive cultural change in our economic model.
- Ways that the MSSP can help your organization achieve financial success.
- Ideas for how to utilize data to develop better healthcare delivery systems.
Dr. Will Caldwell is a strong proponent of the use of data analytics to promote good health and save lives. His area of expertise rests in technology-enabled health care delivery models and value-based care platforms. We hope that you will view this webinar and learn from his 17-years of work as a data-informed clinician.
The Biggest Healthcare Trends of 2019 and What's to Come in 2020Health Catalyst
In our Healthcare Outlook for 2019 webinar, Stephen Grossbart, PhD, and Bobbi Brown, MBA, shared their predictions for the biggest trends of the year. Which predictions panned out and which didn’t? View this webinar as Stephen takes a look back at 2019 and makes his forecast for 2020.
So, what did happen in 2019? Following the 2018 midterm elections, we predicted a divided Congress would not pass policies to strengthen or weaken the Affordable Care Act (ACA). We were right. Meanwhile, Democratic presidential candidates debated the extent to which they would support Medicare for All. Insurance costs continued to rise, breaking $20,000 annually for families with employer-sponsored coverage, and CMS continued to support payment policies rewarding quality and interoperability as part of their payment policy.
Join Stephen as he looks in the rearview mirror at these important issues and how they impacted the healthcare industry in 2019 and then gazes into the crystal ball to predict the trends that will most impact healthcare in 2020. In this webinar, Stephen discusses the following topics and more:
• The continued focus on price transparency.
• Congress’ efforts to control prescription drug costs.
• Policies that may change the future of ACOs.
• What to expect going into the 2020 election year.
The Latest Healthcare Financial Trends: What You Need to KnowHealth Catalyst
As 2017 comes to an end, two of our most experienced and capable people are assessing this year’s most prominent healthcare financial trends and using those clues to better read the tea leaves to predict which trends will impact 2018. Tasked with delivering ground breaking financial software products, Dorian DiNardo, Senior Vice President, Analytics, daily has her finger to the wind to sense how shifting trends are impacting market needs. She will join Bobbi Brown, Senior Vice President, Professional Services, who will lead the webinar conversation. Bobbi has several impressive decades of experience in financial leadership for some of the most storied organizations including Intermountain, Sutter Health and Kaiser Permanente. Among other trends that popup in the next few weeks, she will examine three of 2017’s most significant healthcare trends:
Transitions in payment models
Healthcare market disruptions from well-known companies as well as some not-so-familiar newcomers
Emerging importance of technical data skillsets
3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINOCNseg
The document discusses challenges and opportunities related to medical devices in the US healthcare system. It provides background on AHIP and trends in US healthcare spending and insurance coverage. It then discusses the medical device industry and market, FDA regulation of devices, payment reform efforts toward value-based care, and examples of alternative payment models like bundled payments that aim to reduce costs and improve outcomes.
The document discusses Medicare spending in the United States. It reports that Medicare spending was reduced to 0.2% in 2013 compared to 1.8% between 2009-2012. This decrease may have resulted from the recession limiting spending, delivery system reforms to improve quality while reducing local costs, or a focus on patient-centered care. Statistical data from Medicare budget reports is cited to support the claims around reduced spending.
Urgent Care Market of US to reach USD18.8 billion by 2018 | An Aranca Infogra...Aranca
The urgent care market of US is expected to reach USD 18.8 billion by 2018. Favorable demographics, regulatory framework and growing support from insurers are likely to be the key driving factors of urgent care market.
The Top Three Healthcare Financial Trends in 2017: Payment Transitions, Disru...Health Catalyst
Influential healthcare financial trends in 2017 emerged in three areas:
Transitions in payment.
Disruption from familiar players and newcomers.
Emerging data skillsets.
Uncertainty has been a common theme for 2017. Organizations continue waiting for clarity on the future of the Affordable Care Act (ACA), while working to implement value-based care. Changes from established healthcare organizations as well as the arrival of prominent newcomers (e.g., Amazon) add to the unsettled outlook, as do emerging data skillsets. Amid the uncertainty, however, healthcare is clearly continuing on the path to patient-centered care. Organizations best positioned for 2018 will understand their performance in 2017’s top three healthcare financial trends as they evaluate their preparedness for the coming year.
Similar to Mercer Capital's Value Focus: Healthcare Facilities | Year-End 2017 (20)
Mercer Capital's Bank Watch | September 2023 | The Interest Rate Environment ...Mercer Capital
Brought to you by the Financial Institutions Team of Mercer Capital, this monthly newsletter is focused on bank activity in five U.S. regions. Bank Watch highlights various banking metrics, including public market indicators, M&A market indicators, and key indices of the top financial institutions, providing insight into financial institution valuation issues.
Mercer Capital's Investment Management Industry Newsletter | Q2 2023 | Focus:...Mercer Capital
Mercer Capital’s Investment Management Industry newsletter is a quarterly publication providing perspective on valuation issues pertinent to asset managers, trust companies, and investment consultants.
Mercer Capital's Bank Watch | July 2023 | Bank Impairment TestingMercer Capital
Brought to you by the Financial Institutions Team of Mercer Capital, this monthly newsletter is focused on bank activity in five U.S. regions. Bank Watch highlights various banking metrics, including public market indicators, M&A market indicators, and key indices of the top financial institutions, providing insight into financial institution valuation issues.
Mercer Capital's Value Focus: Transportation & Logistics | Q1 2023 |Mercer Capital
Mercer Capital's Transportation & LogisticsIndustry newsletter provides perspective on valuation issues. Each newsletter also typically includes macroeconomic trends, industry trends, mergers and acquisitions review, and guideline public company metrics.
Mercer Capital's Value Matters™ | Issue No. 1, 2023 Mercer Capital
Mercer Capital's Value Matters™, addresses gift & estate tax, ESOP, buy-sell agreement, and transaction advisory topics of interest to estate planners and other professional advisors to business.
Mercer Capital - Corporate Finance in 30 Minutes Whitepaper.pdfMercer Capital
Corporate finance does not need to be a mystery. In this whitepaper, we distill the
fundamental principles of corporate finance into an accessible and non-technical
primer. Structured around the three key decisions of capital structure, capital
budgeting, and distribution policy, the guide is designed to assist family business directors and shareholders without a finance background make relevant and
meaningful contributions to the most consequential financial decisions all companies must make. Our goal with this whitepaper is to give family business directors
and shareholders a vocabulary and conceptual framework for thinking about strategic corporate finance decisions, allowing them to bring their perspectives and
expertise to the discussion.
Mercer Capital's Bank Watch | March 2023 | “I’m Not Broke. I’m Just Not Liquid.”Mercer Capital
Brought to you by the Financial Institutions Team of Mercer Capital, this monthly newsletter is focused on bank activity in five U.S. regions. Bank Watch highlights various banking metrics, including public market indicators, M&A market indicators, and key indices of the top financial institutions, providing insight into financial institution valuation issues.
Mercer Capital's Bank Watch | February 2023 | Themes from Bank Director’s 202...Mercer Capital
Brought to you by the Financial Institutions Team of Mercer Capital, this monthly newsletter is focused on bank activity in five U.S. regions. Bank Watch highlights various banking metrics, including public market indicators, M&A market indicators, and key indices of the top financial institutions, providing insight into financial institution valuation issues.
Mercer Capital's Investment Management Industry Newsletter | Q4 2023 | Focus:...Mercer Capital
Mercer Capital’s Investment Management Industry newsletter is a quarterly publication providing perspective on valuation issues pertinent to asset managers, trust companies, and investment consultants.
Mercer Capital's Value Focus: Exploration and Production | Fourth Quarter 202...Mercer Capital
Mercer Capital's Energy Industry newsletter provides perspective on valuation issues. Each newsletter also typically includes a macroeconomic trends, industry trends, and guideline public company metrics.
Mercer Capital's Bank Watch | December 2022 | Bank M&A 2022 - TurbulenceMercer Capital
Brought to you by the Financial Institutions Team of Mercer Capital, this monthly newsletter is focused on bank activity in five U.S. regions. Bank Watch highlights various banking metrics, including public market indicators, M&A market indicators, and key indices of the top financial institutions, providing insight into financial institution valuation issues.
Mercer Capital's Value Matters™ | Issue No. 3, 2022|Mercer Capital
Mercer Capital's Value Matters™, published 6 times per year, addresses gift & estate tax, ESOP, buy-sell agreement, and transaction advisory topics of interest to estate planners and other professional advisors to business.
Mercer Capital's Value Focus: Transportation & Logistics | Q3 2022 Mercer Capital
Mercer Capital's Transportation & LogisticsIndustry newsletter provides perspective on valuation issues. Each newsletter also typically includes macroeconomic trends, industry trends, mergers and acquisitions review, and guideline public company metrics.
Mercer Capital's Bank Watch | November 2022 | Community Bank Loan Portfolios ...Mercer Capital
Brought to you by the Financial Institutions Team of Mercer Capital, this monthly newsletter is focused on bank activity in five U.S. regions. Bank Watch highlights various banking metrics, including public market indicators, M&A market indicators, and key indices of the top financial institutions, providing insight into financial institution valuation issues.
Mercer Capital's Investment Management Industry Newsletter | Q3 2022 | Focus:...Mercer Capital
Mercer Capital’s Investment Management Industry newsletter is a quarterly publication providing perspective on valuation issues pertinent to asset managers, trust companies, and investment consultants.
Mercer Capital's Investment Management Industry Newsletter | Q2 2022 | Segmen...Mercer Capital
Mercer Capital’s Investment Management Industry newsletter is a quarterly publication providing perspective on valuation issues pertinent to asset managers, trust companies, and investment consultants.
Mercer Capital's Bank Watch | October 2022 | How Are Tech-Forward Banks Perfo...Mercer Capital
Brought to you by the Financial Institutions Team of Mercer Capital, this monthly newsletter is focused on bank activity in five U.S. regions. Bank Watch highlights various banking metrics, including public market indicators, M&A market indicators, and key indices of the top financial institutions, providing insight into financial institution valuation issues.
Mercer Capital's Value Focus: Transportation & Logistics | Q2 2022 | Feature...Mercer Capital
Mercer Capital's Transportation & LogisticsIndustry newsletter provides perspective on valuation issues. Each newsletter also typically includes macroeconomic trends, industry trends, mergers and acquisitions review, and guideline public company metrics.
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...Vighnesh Shashtri
Under the leadership of Abhay Bhutada, Poonawalla Fincorp has achieved record-low Non-Performing Assets (NPA) and witnessed unprecedented growth. Bhutada's strategic vision and effective management have significantly enhanced the company's financial health, showcasing a robust performance in the financial sector. This achievement underscores the company's resilience and ability to thrive in a competitive market, setting a new benchmark for operational excellence in the industry.
Seminar: Gender Board Diversity through Ownership NetworksGRAPE
Seminar on gender diversity spillovers through ownership networks at FAME|GRAPE. Presenting novel research. Studies in economics and management using econometrics methods.
The Rise of Generative AI in Finance: Reshaping the Industry with Synthetic DataChampak Jhagmag
In this presentation, we will explore the rise of generative AI in finance and its potential to reshape the industry. We will discuss how generative AI can be used to develop new products, combat fraud, and revolutionize risk management. Finally, we will address some of the ethical considerations and challenges associated with this powerful technology.
Financial Assets: Debit vs Equity Securities.pptxWrito-Finance
financial assets represent claim for future benefit or cash. Financial assets are formed by establishing contracts between participants. These financial assets are used for collection of huge amounts of money for business purposes.
Two major Types: Debt Securities and Equity Securities.
Debt Securities are Also known as fixed-income securities or instruments. The type of assets is formed by establishing contracts between investor and issuer of the asset.
• The first type of Debit securities is BONDS. Bonds are issued by corporations and government (both local and national government).
• The second important type of Debit security is NOTES. Apart from similarities associated with notes and bonds, notes have shorter term maturity.
• The 3rd important type of Debit security is TRESURY BILLS. These securities have short-term ranging from three months, six months, and one year. Issuer of such securities are governments.
• Above discussed debit securities are mostly issued by governments and corporations. CERTIFICATE OF DEPOSITS CDs are issued by Banks and Financial Institutions. Risk factor associated with CDs gets reduced when issued by reputable institutions or Banks.
Following are the risk attached with debt securities: Credit risk, interest rate risk and currency risk
There are no fixed maturity dates in such securities, and asset’s value is determined by company’s performance. There are two major types of equity securities: common stock and preferred stock.
Common Stock: These are simple equity securities and bear no complexities which the preferred stock bears. Holders of such securities or instrument have the voting rights when it comes to select the company’s board of director or the business decisions to be made.
Preferred Stock: Preferred stocks are sometime referred to as hybrid securities, because it contains elements of both debit security and equity security. Preferred stock confers ownership rights to security holder that is why it is equity instrument
<a href="https://www.writofinance.com/equity-securities-features-types-risk/" >Equity securities </a> as a whole is used for capital funding for companies. Companies have multiple expenses to cover. Potential growth of company is required in competitive market. So, these securities are used for capital generation, and then uses it for company’s growth.
Concluding remarks
Both are employed in business. Businesses are often established through debit securities, then what is the need for equity securities. Companies have to cover multiple expenses and expansion of business. They can also use equity instruments for repayment of debits. So, there are multiple uses for securities. As an investor, you need tools for analysis. Investment decisions are made by carefully analyzing the market. For better analysis of the stock market, investors often employ financial analysis of companies.
1. Elemental Economics - Introduction to mining.pdfNeal Brewster
After this first you should: Understand the nature of mining; have an awareness of the industry’s boundaries, corporate structure and size; appreciation the complex motivations and objectives of the industries’ various participants; know how mineral reserves are defined and estimated, and how they evolve over time.
2. Elemental Economics - Mineral demand.pdfNeal Brewster
After this second you should be able to: Explain the main determinants of demand for any mineral product, and their relative importance; recognise and explain how demand for any product is likely to change with economic activity; recognise and explain the roles of technology and relative prices in influencing demand; be able to explain the differences between the rates of growth of demand for different products.
Independent Study - College of Wooster Research (2023-2024) FDI, Culture, Glo...AntoniaOwensDetwiler
"Does Foreign Direct Investment Negatively Affect Preservation of Culture in the Global South? Case Studies in Thailand and Cambodia."
Do elements of globalization, such as Foreign Direct Investment (FDI), negatively affect the ability of countries in the Global South to preserve their culture? This research aims to answer this question by employing a cross-sectional comparative case study analysis utilizing methods of difference. Thailand and Cambodia are compared as they are in the same region and have a similar culture. The metric of difference between Thailand and Cambodia is their ability to preserve their culture. This ability is operationalized by their respective attitudes towards FDI; Thailand imposes stringent regulations and limitations on FDI while Cambodia does not hesitate to accept most FDI and imposes fewer limitations. The evidence from this study suggests that FDI from globally influential countries with high gross domestic products (GDPs) (e.g. China, U.S.) challenges the ability of countries with lower GDPs (e.g. Cambodia) to protect their culture. Furthermore, the ability, or lack thereof, of the receiving countries to protect their culture is amplified by the existence and implementation of restrictive FDI policies imposed by their governments.
My study abroad in Bali, Indonesia, inspired this research topic as I noticed how globalization is changing the culture of its people. I learned their language and way of life which helped me understand the beauty and importance of cultural preservation. I believe we could all benefit from learning new perspectives as they could help us ideate solutions to contemporary issues and empathize with others.
Abhay Bhutada, the Managing Director of Poonawalla Fincorp Limited, is an accomplished leader with over 15 years of experience in commercial and retail lending. A Qualified Chartered Accountant, he has been pivotal in leveraging technology to enhance financial services. Starting his career at Bank of India, he later founded TAB Capital Limited and co-founded Poonawalla Finance Private Limited, emphasizing digital lending. Under his leadership, Poonawalla Fincorp achieved a 'AAA' credit rating, integrating acquisitions and emphasizing corporate governance. Actively involved in industry forums and CSR initiatives, Abhay has been recognized with awards like "Young Entrepreneur of India 2017" and "40 under 40 Most Influential Leader for 2020-21." Personally, he values mindfulness, enjoys gardening, yoga, and sees every day as an opportunity for growth and improvement.
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby...Donc Test
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting, 8th Canadian Edition by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Ebook Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Pdf Solution Manual For Financial Accounting 8th Canadian Edition Pdf Download Stuvia Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Financial Accounting 8th Canadian Edition Ebook Download Stuvia Financial Accounting 8th Canadian Edition Pdf Financial Accounting 8th Canadian Edition Pdf Download Stuvia